Effects of Metformin and its Combination with Teneligliptin or Empagliflozin on Bone Turnover Markers in Patients with Type 2 Diabetes Mellitus a prospective study
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
newline